US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
You may also like
A valuation of 8 billion dollars, doubling in 8 months! What makes the crypto-friendly bank Erebor Bank stand out?
340 billion valuation: Li Yanhong's largest IPO, a seat in Kunlunxin's shares is hard to come by
Stablecoins are the "royalists" of the crypto world: Open USD brings the old currency system into play
Semiconductor stocks plummet, yet Anthropic wants to create a 2nm chip
Where is Zhao Changpeng's billion-dollar investment going? YZi Labs' investment landscape fully revealed
Ethereum Foundation Report: A Basic Guide to Ethereum for Governments and Financial Institutions
A pre-announced harvesting case: After the cryptocurrency price dropped by 99%, the public chain Saga exited to transform into AI
When American giants collectively "defect" from Chinese AI models
BIS Report Compliance Observation: The Real Risks of Stablecoins, Not Just "Depegging"
Portugal 2-1 Croatia: Ronaldo's 20-Year Knockout-Stage Drought Ends With a Debt Finally Collected
Portugal beat Croatia 2-1 in the 2026 global football championship's knockout rounds as Ronaldo scored his first-ever knockout-stage goal, Gonçalo Ramos struck a stoppage-time winner, and VAR ruled out a late equalizer for offside.
